Patents by Inventor Prasad Dixit

Prasad Dixit has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 1,6- DIAZABICYCLO [3,2,1] OCTAN-7-ONE DERIVATIVES AND THEIR USE IN THE TREATMENT OF BACTERIAL INFECTIONS
    Publication number: 20200071328
    Abstract: Compounds of Formula (I), their preparation and use in preventing or treating bacterial infections are disclosed.
    Type: Application
    Filed: November 7, 2019
    Publication date: March 5, 2020
    Applicant: WOCKHARDT LIMITED
    Inventors: Vijaykumar Jagdishwar PATIL, Ravikumar TADIPARTHI, Bharat DOND, Amol KALE, Loganathan VELUPILLAI, Deepak DEKHANE, Satish Shrimant BIRAJDAR, Mohammad Usman SHAIKH, Sushilkumar MAURYA, Piyush Ambalal PATEL, Prasad DIXIT, Mangesh PAWAR, Mahesh Vithalbhai PATEL, Sachin BHAGWAT
  • 1,6-diazabicyclo [3,2,1] octan-7-one derivatives and their bacterial infections
    Patent number: 10519155
    Abstract: Compounds of Formula (I), their preparation and use in preventing or treating bacterial infections are disclosed.
    Type: Grant
    Filed: February 17, 2018
    Date of Patent: December 31, 2019
    Assignee: WOCKHARDT LIMITED
    Inventors: Vijaykumar Jagdishwar Patil, Ravikumar Tadiparthi, Bharat Dond, Amol Kale, Loganathan Velupillai, Deepak Dekhane, Satish Shrimant Birajdar, Mohammad Usman Shaikh, Sushilkumar Maurya, Piyush Ambalal Patel, Prasad Dixit, Mangesh Pawar, Mahesh Vithalbhai Patel, Sachin Bhagwat
  • DIFLUORO-(2-SUBSTITUTED CARBAMOYL-1,6-DIAZA-BICYCLO [3.2.1] OCT-6-YLOXY) ACETIC ACID COMPOUNDS AND THEIR USE IN TREATMENT OF BACTERIAL INFECTIONS
    Publication number: 20190077802
    Abstract: The invention discloses compounds of Formula (I), their preparation, and their use in treating a bacterial infection.
    Type: Application
    Filed: October 5, 2016
    Publication date: March 14, 2019
    Applicant: WOCKHARDT LIMITED
    Inventors: Vijaykumar Jagdishwar PATIL, Sushikumar MAURYA, Bharat DOND, Velupillai LOGANATHAN, Deepak DEKHANE, Prasad DIXIT, Prashant JOSHI, Swapna TAKALKAR, Mahesh Vithalbhai PATEL
  • 1,6- DIAZABICYCLO [3,2,1] OCTAN-7-ONE DERIVATIVES AND THEIR USE IN THE TREATMENT OF BACTERIAL INFECTIONS
    Publication number: 20180170930
    Abstract: Compounds of Formula (I), their preparation and use in preventing or treating bacterial infections are disclosed.
    Type: Application
    Filed: February 17, 2018
    Publication date: June 21, 2018
    Applicant: WOCKHARDT LIMITED
    Inventors: Vijaykumar Jagdishwar PATIL, Ravikumar Tadiparthi, Bharat Dond, Amol Kale, Loganathan Velupillai, Deepak Dekhane, Satish Shrimant Birajdar, Mohammad Usman Shaikh, Sushilkumar Maurya, Piyush Ambalal Patel, Prasad Dixit, Mangesh Pawar, Mahesh Vithalbhai Patel, Sachin Bhagwat
  • 1,6-diazabicyclo [3,2,1] octan-7-one derivatives and their use in the treatment of bacterial infections
    Patent number: 9732081
    Abstract: Compounds of Formula (I), their preparation and use in preventing or treating bacterial infections are disclosed.
    Type: Grant
    Filed: March 6, 2016
    Date of Patent: August 15, 2017
    Inventors: Vijaykumar Jagdishwar Patil, Ravikumar Tadiparthi, Bharat Dond, Amol Kale, Loganathan Velupillai, Deepak Dekhane, Satish Shrimant Birajdar, Mohammad Usman Shaikh, Sushilkumar Maurya, Piyush Ambalal Patel, Prasad Dixit, Mangesh Pawar, Mahesh Vithalbhai Patel, Sachin Bhagwat
  • 1,6- DIAZABICYCLO [3,2,1] OCTAN-7-ONE DERIVATIVES AND THEIR USE IN THE TREATMENT OF BACTERIAL INFECTIONS
    Publication number: 20160311822
    Abstract: Compounds of Formula (I), their preparation and use in preventing or treating bacterial infections are disclosed.
    Type: Application
    Filed: July 4, 2016
    Publication date: October 27, 2016
    Inventors: Vijaykumar Jagdishwar PATIL, Ravikumar TADIPARTHI, Bharat DOND, Amol KALE, Loganathan VELUPILLAI, Deepak DEKHANE, Satish Shrimant BIRAJDAR, Mohammad Usman SHAIKH, Sushilkumar MAURYA, Piyush Ambalal PATEL, Prasad DIXIT, Mangesh PAWAR, Mahesh Vithalbhai PATEL, Sachin BHAGWAT
  • 1,6- DIAZABICYCLO [3,2,1] OCTAN- 7- ONE DERIVATIVES AND THEIR USE IN THE TREATMENT OF BACTERIAL INFECTIONS
    Publication number: 20160213655
    Abstract: Compounds of Formula (I), their preparation and use in preventing or treating bacterial infections are disclosed.
    Type: Application
    Filed: March 6, 2016
    Publication date: July 28, 2016
    Inventors: Vijaykumar Jagdishwar PATIL, Ravikumar TADIPARTHI, Bharat DOND, Amol KALE, Loganathan VELUPILLAI, Deepak DEKHANE, Satish Shrimant BIRAJDAR, Mohammad Usman SHAIKH, Sushilkumar MAURYA, Piyush Ambalal PATEL, Prasad DIXIT, Mangesh PAWAR, Mahesh Vithalbhai PATEL, Sachin BHAGWAT
  • 1,6- DIAZABICYCLO [3,2,1] OCTAN-7-ONE DERIVATIVES AND THEIR USE IN THE TREATMENT OF BACTERIAL INFECTIONS
    Publication number: 20150203503
    Abstract: Compounds of Formula (I), their preparation and use in preventing or treating bacterial infections are disclosed.
    Type: Application
    Filed: April 19, 2013
    Publication date: July 23, 2015
    Applicant: WOCKHARDT LIMITED
    Inventors: Vijaykumar Jagdishwar Patil, Ravikumar Tadiparthi, Bharat Dond, Amol Kale, Loganathan Velupillai, Deepak Dekhane, Satish Shrimant Birajdar, Mohammad Usman Shaikh, Sushilkumar Maurya, Piyush Ambalal Patel, Prasad Dixit, Mangesh Pawar, Mahesh Vithalbhai Patel, Sachin Bhagwat
  • Novel antimycobacterial compounds
    Publication number: 20050192275
    Abstract: Novel compounds belonging to the class of oxazolidinones possessing potent antimycobacterial properties especially useful in the treatment of acid fast organisms such as Mycobacterium tuberculosis, Mycobacterium avium-intracellular complex, M. fortuitum and M. kansai. The compound and its pharmaceutically acceptable salts thereof act as antibacterial agents. Also disclosed is a method for inhibiting growth of mycobacterial cells as well as a method of treating mycobacterial conditions such as Mycobacterium tuberculosis, drug resistant Mycobacterium tuberculosis, Mycobacterium avium-intracellular complex, M. fortuitum and M. kansai, comprising administering an antimycobacterially effective amount of the said compound and/or pharmaceutically acceptable salts thereof. There is also disclosed a process for the manufacture of the said compound or its pharmaceutically acceptable salts.
    Type: Application
    Filed: March 18, 2005
    Publication date: September 1, 2005
    Inventors: Sudershan Arora, Vijaykumar Patil, Prathap Nair, Prasad Dixit, Shankar Ajay, Rakesh Sinha